Introduction
============

Carotid atherosclerosis is a very common disease in cardiova-scular medicine, and it is the basis of cerebral vascular disease such as stroke. There are approximately sixty percent stroke patients related to it. It is one of the main causes of death worldwide ([@b1-etm-0-0-7088],[@b2-etm-0-0-7088]). It is reported that the incidence of carotid atherosclerosis has declined in developed countries in recent years, while increased in developing countries, which may result from dietary patterns changing caused by economic development, because high-fat diet and low-cholesterol consumption play a very important role in the pathogenesis of carotid atherosclerosis ([@b3-etm-0-0-7088],[@b4-etm-0-0-7088]).

Among non-invasive examination methods, CT angio-graphy is a widely used method in the diagnosis of carotid and cervical atherosclerosis. It is a popular technique for diagnosis of carotid atherosclerosis as it is fast, convenient, repeatable and its temporal resolution is high ([@b5-etm-0-0-7088],[@b6-etm-0-0-7088]). However, CT angio-graphy is not suitable for all patients. It is closely related to the heart rate and blood flow status of the patient. The slow flow of blood may cause inadequate imaging, and the CT angiography cannot be used in patients with contrast agent. It is closely related to the heart rate ([@b7-etm-0-0-7088],[@b8-etm-0-0-7088]). In recent years, the diagnosis of serology and the diagnosis of molecular biology are very popular directions of study. IL-17 and IL-18 are two molecules associated with atherosclerosis. It is reported that the level of IL-17 protein and mRNA in the peripheral blood of patients with acute coronary syndrome is significantly higher than that of healthy subjects ([@b9-etm-0-0-7088]). IL-18 can induce the expression of γ interferon, a proinflammatory cytokine, which is reported to be involved in the rupture of atherosclerotic plaques ([@b10-etm-0-0-7088]). Therefore, we speculate that IL-17 and IL-18 have the diagno-sis value of carotid atherosclerosis.

In this study, we compared and analyzed the diagnostic value of IL-17 combined with IL-18 and CT angiography in 158 patients with suspected carotid artery stenosis in order to provide a reference for the clinical diagnosis of carotid atherosclerosis.

Materials and methods
=====================

### Clinical data

From March 2014 to April 2017 in People\'s Hospital of Dongying (Dongying, China), 158 patients with suspected carotid stenosis were selected as the subjects. One hundred and two patients with carotid atherosclerosis were selected as the atherosclerosis group. The other 56 patients with no obvious carotid artery abnormalities were selected as the disease control group, and there were 100 healthy subjects selected in the same period after health examination as the healthy control group. Carotid atherosclerosis conforms to the diagnostic standard of International Atherosclerosis Society ([@b11-etm-0-0-7088]), which included patients with suspected ischemic cerebrovascular disease with or without clinical symptoms, and excluded patients with carotid stenosis caused by arterial dissection, patients with stable vital signs, no obvious contraindication, and patients with coronary heart disease, patients with intermittent myocardial infarction, patients with acute myocardial infarction, patients with cerebral atherosclerosis, patients with infectious disease, patients with severe cardiac insufficiency, tumor patients, patients with grade III hypertension, patients with liver and kidney failure, patients with incomplete case information, and patients with mental or learning disability. The control group underwent physical examination to exclude organic diseases and Alzheimers disease. This study was approved by the Ethics Committee of People\'s Hospital of Dongying, and the patients or their family members signed an informed consent.

### ELISA detection of IL-17 and IL-18

The levels of IL-17 and IL-18 in peripheral blood of three groups of patients were detected, and the peripheral blood of patients in the morning under fasting condition was collected by nurses in People\'s Hospital of Dongying. IL-17 test kit was purchased from R&D Systems, Inc. (Minneapolis, MN, USA) and IL-18 test kit was purchased from Beijing Keyingmei Technology (Beijing, China). ELISA was used to determine the level of IL-17 and IL-18 in the samples. First, the standard curve of IL-17 and IL-18 was established, then blank, standard and sample wells were set up, and standard sample was added to enzyme labeled well precoated with primary IL-17 or IL-18 monoclonal antibody (dilution, 1:300; cat. nos. HS750, D8000C; R&D Systems, Inc.) followed by incubation at 37°C for 30 min. After washing, horseradish peroxidase labeled IL-17 or IL-18 antibodies were added. After incubation at 37°C for 30 min, the unbound enzyme was removed, then the substrate was added to show color at room temperature without light. In 15 min, the absorba-nce value (OD value) of each well at 450 nm wavelength was read under the blank well, and the amount of OD value was positively correlated with the concentration of IL-17 or IL-18 in the sample. Three groups of repeated wells were set up, and the experiment was repeated 3 times.

### CT angiography

CT angiography was performed in the atherosclerosis and disease control groups. The scanning equipment was GE Company Light Speed VCT (GE Healthcare, Milwaukee, WI, USA). The scan ranges from the arterial arch to the upper edge of the external auricle. The first sequence is plain scanning, and the second sequence is enhancement scanning with unchangeable parameters. Scanning parameters: voltage 120 KV, current 300--500 mA, detector width 128 mm × 0.625 mm, layer thickness 0.9 mm, layer spacing 0.5 mm, alignment 0.625 mm, FOV 180 mm, screw pitch 0.984, spherical tube rotation speed 0.5 sec/rot. The nonionic contrast agent used for the VCT examination was omnipaque produced by GE Pharmaceutical Co., Ltd. (Shanghai, China). By injection of the anterior elbow vein, the rate of 4--4.4 ml/sec, the quantitative injection of 60--80 ml, and then the addition of the physiological saline 40 ml, image processing technology is used to display lesions on AM4.4 workstation. Two experienced radiologists used double blind methods to diagnose the images respectively.

### Statistical analysis

SPSS19.0 \[AsiaAnalytics (formerly SPSS China), Shanghai, China\] was used. Enumeration data were expressed in (n, %), and χ^2^ test was used for comparison of the rates. The measurement data were expressed as mean ± standard deviation. ANOVA was used for comparison among the multiple groups, and LSD test was used for comparison between the two groups. The receiver operating curve (ROC) was used to analyze the diagnostic value. P\<0.05 was consi-dered to indicate a statistically significant difference.

Results
=======

### Clinical data

There were 158 cases of suspected carotid artery stenosis, among which 102 patients with carotid atherosclerosis in the atherosclerosis group, including 72 male and 30 female patients, with an average age of 52.5±11.4 years and 56 patients in the disease control group, including 32 male and 24 female patients, with an average age of 54.6±12.5 years. There were 100 healthy subjects in the healthy control group, including 52 males and 48 females, with an average age of 49.7±13.3 years. There was no significant difference among the three groups in basic data such as weight, age, sex, smoking history and exercise habits (P\>0.05). The proportion of patients with hypertension, hyperlipidemia and diabetes in the atherosclerosis group was significantly higher than that in the disease control group (P\<0.05) ([Table I](#tI-etm-0-0-7088){ref-type="table"}).

### Detection results of IL-17 and IL-18

The results of IL-17 and IL-18 test detected by ELISA in the three groups of patients showed that the levels of IL-17 and IL-18 in the three groups were all different. The levels of IL-17 and IL-18 in the atherosclerosis and disease control groups were higher than that in the healthy control group (P\<0.05), and IL-17 and IL-18 levels in the atherosclerosis group were higher than those in the disease control group (P\<0.05) ([Table II](#tII-etm-0-0-7088){ref-type="table"}; [Fig. 1](#f1-etm-0-0-7088){ref-type="fig"}).

### Analysis of diagnostic value of CT angiography, IL-17 and IL-18 in 158 patients with suspected carotid atherosclerosis

The coincidence rate and the sensitivity of carotid atherosclerosis diagnosed by diagnostic criteria of IL-17 and IL-18 were less than those diagnosed by the diagnostic criteria of IL-17 combined with IL-18 (P\<0.05), AUC was also less than AUC of IL-17 combined with IL-18 (P\>0.05), and there was no significant difference among the three groups in specificity (P\>0.05). The sensitivity and diagnostic accuracy of IL-17 combined with IL-18 in the diagnosis of carotid atherosclerosis were not significantly different from CT angiography (P\>0.05), but the specificity was significantly lower than CT angiography (P\<0.05) ([Table III](#tIII-etm-0-0-7088){ref-type="table"}; [Fig. 2](#f2-etm-0-0-7088){ref-type="fig"}).

Discussion
==========

Carotid atherosclerosis poses a serious threat to human health. Approximately 60% of stroke patients are associated with carotid atherosclerosis, with a high incidence and mortality rate worldwide ([@b12-etm-0-0-7088],[@b13-etm-0-0-7088]). Therefore, accurate diagnosis of carotid atherosclerosis is very important in clinical treatment. Although the CT angiography is more economical than the whole brain angiography, the diagnostic coincidence rate is not ideal. Cerebral angiography is still needed even if CT angiography is used to detect the lesion, which is too expensive for many patients ([@b14-etm-0-0-7088],[@b15-etm-0-0-7088]). IL-17 and IL-18 have an abnormal expression in the peripheral blood of atherosclerotic patients ([@b9-etm-0-0-7088],[@b10-etm-0-0-7088]). Therefore, the diagnostic value of IL-17 and IL-18 in the carotid artery is analyzed by detecting the level of IL-17 and IL-18 in the patients\' serum, so as to provide help for the clinical diagnosis of carotid atherosclerosis.

This study analyzed the level of IL-17 and IL-18 in periphe-ral blood of 158 patients with suspected carotid artery stenosis, and the basic data such as age and sex in the three groups were not different, which suggested that the study has a certain credi-bility. The levels of IL-17 and IL-18 in the three groups were all statistically different. The level of IL-17 and IL-18 in the peripheral blood of 102 patients with carotid atherosclerosis were significantly higher than those in the disease control and healthy control groups. This may be related to the proportion of the three groups of patients with hypertension, hyperlipidemia and diabetes. The proportion of patients with hypertension, hyperlipidemia and diabetes in the atherosclerosis group were all higher than those in the disease control group, and the healthy control group excluded patients with hypertension, hyperlipi-demia and diabetes. In many studies, the level of IL-17 and IL-18 in the peripheral blood of the patients with the three symptoms increased significantly ([@b16-etm-0-0-7088]--[@b19-etm-0-0-7088]). The elevated levels of IL-17 and IL-18 may also be associated with the rupture of atherosclerotic plaques. The rupture of the plaque caused vascular endothelial damage, the aggravation of the patient\'s inflammatory response and the increase of the level of IL-17 and IL-18 in the periphe-ral blood of the patients ([@b20-etm-0-0-7088],[@b21-etm-0-0-7088]). Therefore, IL-17 and IL-18 as a diagnostic molecule for carotid atherosclerosis have a certain feasibility. Therefore, we analyzed the diagnostic value of IL-17 and IL-18 in carotid atherosclerosis. The results of ROC ana-lysis showed that diagnosing cervical arteriosclerosis by IL-17 alone, AUC was 0.912, the diagnostic level was 13.45 ng/l, and the diagnostic coincidence rate, sensitivity and specificity were 75.3, 68.6 and 87.5% respectively. Diagnosing cervical arteriosclerosis by IL-18 alone, AUC was 0.750, the diagnostic level was 279.5 ng/ml and the diagnostic coincidence rate, sensitivity and specificity were 70.9, 62.7 and 85.7% respectively. The AUC, diagnostic coincidence rate and sensitivity diagnosed by IL-17 combined with IL-18 were all higher than the separate diagnosis, and the AUC was 0.931, with higher diagnostic value. Compared with CT angiography, although the specificity was significantly lower than CT angiography, the sensitivity and diagnostic coincidence rate of IL-17 combined with IL-18 in the diagnosis of carotid atherosclerosis were not significantly different from CT angiography. Therefore, it was feasible to detect carotid atherosclerosis by using the serological method to detect the levels of IL-17 and IL-18. It could be better to screen the carotid atherosclerosis, because its methodology is simple, and it has economic benefits with no adverse reactions, which is suitable for a wide range of individuals and will not create a physical or psychological burden to patients ([@b22-etm-0-0-7088]). There are few reports on IL-17 and IL-18 for the diagnosis of carotid atherosclerosis and few reports of IL-17 combined with IL-18 for the diagnosis of the disease. However, there are many more reports on the diagnosis of cancer by IL-17 and on the diagnosis of arthritis by IL-18, which both have a good value in the diagnosis of disease ([@b23-etm-0-0-7088],[@b24-etm-0-0-7088]). Therefore, the results of this study have a certain credibility, but more experimental studies are still needed to prove it. In addition, IL-17 and IL-18 may also have some defects in the diagnosis of carotid atherosclerosis. Carotid dissection is also an important cause of carotid stenosis. Due to the tear of the artery intima, the inflammatory reaction may also cause the increase of the levels of IL-17 and IL-18 ([@b25-etm-0-0-7088],[@b26-etm-0-0-7088]). Therefore, no patients with carotid artery dissection was included in this study. We hope that our study can induce more scholars to explore the molecular level on the diagnosis of carotid atherosclerosis.

In conclusion, IL-17 combined with IL-18 has a high diagno-stic value for atherosclerosis, and can be used as a routine method for screening and diagnosing atherosclerosis.
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![(A) The results of IL-17 test. The levels of IL-17 in the three groups were all different; the levels of IL-17 in the atherosclerosis and disease control groups were higher than those in the healthy control group (^a^P\<0.05), and the level of IL-17 in the atherosclerosis group was higher than that in the disease control group (^a^P\<0.05). (B) The results of IL-18 test. The levels of IL-18 in the three groups were all different; the levels of IL-18 in the atherosclerosis and disease control groups were higher than those in the healthy control group (^a^P\<0.05), and the level of IL-18 in the atherosclerosis group was higher than that in the disease control group (^a^P\<0.05).](etm-17-02-1400-g00){#f1-etm-0-0-7088}

![The ROC curves of IL-17 and IL-18 alone and IL-17 combined with IL-18 to diagnose carotid atherosclerosis. The coincidence rate and the sensitivity of carotid atherosclerosis diagnosed by diagnostic criteria of IL-17 and IL-18 were less than those diagnosed by the diagnostic criteria of IL-17 combined with IL-18 (P\<0.05). AUC was also less than AUC of IL-17 combined with IL-18 (P\>0.05), and there was no significant difference among the three groups in specificity (P\>0.05). AUC (IL-17) = 0.912, AUC (IL-18) = 0.750, AUC (IL-17 and IL-18) = 0.931.](etm-17-02-1400-g01){#f2-etm-0-0-7088}

###### 

Comparison of the basic data.

  Factors                     Atherosclerosis group   Disease control group   Healthy control group   F/χ^2^   P-value
  --------------------------- ----------------------- ----------------------- ----------------------- -------- ---------
  No. of patients             102                     56                      100                              
  Male/female                 72/30                   32/24                   52/48                   2.629    0.302
  Age (years)                 52.5±11.4               54.6±12.5               49.7±13.3               3.028    0.050
  Hypertension (n, %)         82 (80.4)               10 (17.9)                                       58.125   \<0.001
  Hyperlipidemia (n, %)       86 (84.3)               14 (25.0)                                       54.743   \<0.001
  Diabetes (n, %)             32 (31.4)               5 (8.9)                                         10.154   0.001
  Weight (n, %)                                                                                       0.353    0.828
    ≥60 kg                    63 (61.8)               32 (57.1)               59 (59.0)                        
    \<60 kg                   39 (38.2)               24 (42.9)               41 (41.0)                        
  History of smoking (n, %)                                                                           2.097    0.351
    Positive                  52 (51.0)               23 (41.1)               43 (43.0)                        
    Negative                  50 (49.0)               33 (58.9)               57 (57.0)                        
  Exercise habits (n, %)                                                                              2.329    0.312
    Negative                  68 (66.7)               39 (69.6)               65 (65.0)                        
    Positive                  34 (33.3)               17 (30.4)               35 (35.0)                        

###### 

The results of IL-17 and IL-18 test.

  Factors           Atherosclerosis group   Disease control group                                                                                   Healthy control group                                                                                   F-value   P-value
  ----------------- ----------------------- ------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------- --------- ---------
  No. of patients   102                     56                                                                                                      100                                                                                                               
  IL-17 (ng/l)      30.35±5.12              21.12±3.33^[a](#tfn1-etm-0-0-7088){ref-type="table-fn"}^                                                10.32±2.45^[a](#tfn1-etm-0-0-7088){ref-type="table-fn"},[b](#tfn2-etm-0-0-7088){ref-type="table-fn"}^   674.867   \<0.001
  IL-18 (ng/ml)     336.5±132.5             214.7±58.9^[a](#tfn1-etm-0-0-7088){ref-type="table-fn"},[b](#tfn2-etm-0-0-7088){ref-type="table-fn"}^   114.9±30.6^[a](#tfn1-etm-0-0-7088){ref-type="table-fn"},[b](#tfn2-etm-0-0-7088){ref-type="table-fn"}^   154.326   \<0.001

P\<0.05, compared with the atherosclerosis group.

P\<0.05, compared with the disease control group.

###### 

Analysis of diagnostic value of IL-17 and IL-18 for carotid atherosclerosis.

  Factors                              IL-17          IL-18          IL-17 combined with IL-18                                  CT angiography
  ------------------------------------ -------------- -------------- ---------------------------------------------------------- ----------------------------------------------------------
  AUC                                  0.912          0.750          0.931                                                      
  95% confidence interval              0.870--0.954   0.674--0.823   0.893--0.968                                               
  Diagnostic standard                  13.45 ng/l     279.5 ng/ml                                                               
  Sensitivity (%, n)                   68.6 (70)      62.7 (64)      77.5 (79)^[a](#tfn3-etm-0-0-7088){ref-type="table-fn"}^    73.5 (75)^[a](#tfn3-etm-0-0-7088){ref-type="table-fn"}^
  Specificity (%, n)                   87.5 (49)      85.7 (48)      82.1 (46)                                                  94.6 (53)^[b](#tfn4-etm-0-0-7088){ref-type="table-fn"}^
  Diagnostic coincidence rate (%, n)   75.3 (119)     70.9 (112)     81.6 (129)^[a](#tfn3-etm-0-0-7088){ref-type="table-fn"}^   81.0 (128)^[a](#tfn3-etm-0-0-7088){ref-type="table-fn"}^

P\<0.05, compared with IL-17 and IL-18 for each.

P\<0.05, compared with IL-17 and IL-18 and IL-17 combined with IL-18 for each.
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